| mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.096 |
0.08 |
| mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
0.059 |
0.08 |
| mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.09 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.09 |
| mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.09 |
| mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.09 |
| mRNA |
ABT-263 |
FIMM |
pan-cancer |
AAC |
0.26 |
0.09 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.09 |
| mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.09 |
| mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.09 |